CVR Medical Corp. announced the addition of Mr. Wayne Hellman to its Board of Directors and appointment as Vice Chairman. Mr. Hellman will assume an active role focused on the continued development and upcoming launch of CVR Medical's novel medical device, the "Carotid Stenotic Scan (CSS)." Mr. Hellman's career spans forty years having spent 16 years in various senior management roles with General Electric, culminating with the final four years reporting directly to Jack Welch (Chairman/CEO) where he led GE's Venture Lighting Portfolio. Mr. Hellman's immense expertise in, product development and launches of novel technologies have shown a strong capacity for new applications with the potential to disrupt industries. As CVR Medical completes its Pivotal Trials (Cleveland Clinic & Henry Ford Hospital), rapidly approaching its planned FDA submission and ultimately preparing the CSS for market launch, he will be instrumental in its transition process from a research and development-based company to one focused on sales and marketing. Mr. Hellman's contributions, reputation and network of global influencers has already proven invaluable to CVR Medical, resulting in the company conducting its Pivotal Trial at The Cleveland Clinic and other global entities in South Korea expressing interest in exploring various collaborations.